Grant: Catalyst Grant: Analysis of CLSA Data
University of Alberta
$69,535.00
Prevalence and Health Implications of Sarcopenia and Sarcopenic Obesity in Canada
EF 2016-17
Résumé
Low muscle mass also termed sarcopenia is prevalent among people of elder age and leads to a loss of physical function and independence, decreased quality of life, and increased morbidity and mortality. With the increasing prevalence of obesity among elder adults, the prevalence of combined sarcopenia and obesity (sarcopenic obesity) is at rise. Evidence suggests people who have both these conditions have poorer overall health. To date, no population studies have been done in Canadian older adults to investigate the prevalence and impact of these sarcopenia and sarcopenic obesity.
Sarcopenia will be officially recognized as a disease as of October 2016, but its diagnosis remains debatable. We propose to use the Canadian Longitudinal Study on Aging to explore diagnostic criteria, as well as the prevalence and health implications of sarcopenia and sarcopenic obesity in Canada.
Programme
Catalyst Grant: Analysis of CLSA Data
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
353054
Name
Prado Carla M
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Clinical
Prcname2
Catalyst Grant: Analysis of CLSA Data
Projecttitle
Prevalence and Health Implications of Sarcopenia and Sarcopenic Obesity in Canada
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$69,535
Cihrequipment2
$0
Programname2
Catalyst Grant: Analysis of CLSA Data
Keyworddelim
Activities Of Daily Living; Aging; Body Composition; Muscle Mass; Muscle Strength; Physical Function; Sarcopenia; Sarcopenic Obesity
Abstract
Low muscle mass also termed sarcopenia is prevalent among people of elder age and leads to a loss of physical function and independence, decreased quality of life, and increased morbidity and mortality. With the increasing prevalence of obesity among elder adults, the prevalence of combined sarcopenia and obesity (sarcopenic obesity) is at rise. Evidence suggests people who have both these conditions have poorer overall health. To date, no population studies have been done in Canadian older adults to investigate the prevalence and impact of these sarcopenia and sarcopenic obesity.
Sarcopenia will be officially recognized as a disease as of October 2016, but its diagnosis remains debatable. We propose to use the Canadian Longitudinal Study on Aging to explore diagnostic criteria, as well as the prevalence and health implications of sarcopenia and sarcopenic obesity in Canada.
Competitiondate
201608
Approvedterm2
1 yr 0 mth
Pinamesdelim
Prado, Carla M
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Musculoskel Hlth &Arth~ $69,535~ $0~